Eduardo Caleiras

1.2k total citations
37 papers, 291 citations indexed

About

Eduardo Caleiras is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eduardo Caleiras has authored 37 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Eduardo Caleiras's work include Renal cell carcinoma treatment (4 papers), T-cell and B-cell Immunology (4 papers) and Cancer-related Molecular Pathways (3 papers). Eduardo Caleiras is often cited by papers focused on Renal cell carcinoma treatment (4 papers), T-cell and B-cell Immunology (4 papers) and Cancer-related Molecular Pathways (3 papers). Eduardo Caleiras collaborates with scholars based in Spain, Venezuela and United States. Eduardo Caleiras's co-authors include Miguel Quintela-Fandiño, Silvana Mourón, Luís Manso, Carlos Caldas, Carlos González, Renzo Nino Incani, Oscar M. Rueda, María J. Bueno, José Luis Rodríguez‐­Peralto and Rámón Colomer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eduardo Caleiras

33 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Caleiras Spain 11 157 79 66 53 40 37 291
Chan Zhu China 11 139 0.9× 40 0.5× 30 0.5× 61 1.2× 72 1.8× 30 312
David Crawford United States 12 210 1.3× 29 0.4× 60 0.9× 72 1.4× 54 1.4× 22 418
Núria Coll-Bonfill Spain 13 287 1.8× 72 0.9× 83 1.3× 35 0.7× 94 2.4× 16 430
Dong Qian China 11 209 1.3× 145 1.8× 54 0.8× 88 1.7× 87 2.2× 17 391
Joanne Cox United Kingdom 7 220 1.4× 41 0.5× 39 0.6× 67 1.3× 104 2.6× 8 439
Louise Munkhaus Petersen Denmark 3 252 1.6× 31 0.4× 70 1.1× 95 1.8× 108 2.7× 4 354
Christine Birdwell United States 9 255 1.6× 33 0.4× 19 0.3× 86 1.6× 72 1.8× 32 421
Doran Khamis United Kingdom 5 209 1.3× 44 0.6× 17 0.3× 54 1.0× 81 2.0× 7 339
Yueh‐Te Lin Taiwan 7 326 2.1× 110 1.4× 44 0.7× 82 1.5× 62 1.6× 10 459
Ke Zheng China 11 160 1.0× 76 1.0× 19 0.3× 58 1.1× 35 0.9× 18 275

Countries citing papers authored by Eduardo Caleiras

Since Specialization
Citations

This map shows the geographic impact of Eduardo Caleiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Caleiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Caleiras more than expected).

Fields of papers citing papers by Eduardo Caleiras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Caleiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Caleiras. The network helps show where Eduardo Caleiras may publish in the future.

Co-authorship network of co-authors of Eduardo Caleiras

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Caleiras. A scholar is included among the top collaborators of Eduardo Caleiras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Caleiras. Eduardo Caleiras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández-Porras, Isabel, Lucía Simón-Carrasco, Matthias Drosten, et al.. (2025). Systemic Kras ablation disrupts myeloid cell homeostasis in adult mice. Proceedings of the National Academy of Sciences. 122(34). e2512404122–e2512404122. 2 indexed citations
2.
Santos, Vanesa, Marina S. Mazariegos, Eduardo Caleiras, et al.. (2024). NGFR regulates stromal cell activation in germinal centers. Cell Reports. 43(2). 113705–113705. 3 indexed citations
3.
Ortega-Molina, Ana, Cristina Lebrero‐Fernández, Miguel Calvo‐Rubio, et al.. (2024). A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan. Nature Aging. 4(8). 1102–1120. 16 indexed citations
4.
Deleyto-Seldas, Nerea, Fernando Garcı́a, Eduardo Caleiras, et al.. (2024). Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver. Nature Communications. 15(1). 1878–1878. 4 indexed citations
5.
Bueno, María J., Silvana Mourón, Eduardo Caleiras, et al.. (2023). Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation. Clinical & Translational Oncology. 26(5). 1273–1279.
6.
Martín, Alberto, Carolina Epifano, Rocı́o I.R. Macı́as, et al.. (2022). Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers. Cell Death and Differentiation. 30(1). 37–53. 17 indexed citations
7.
Lechuga, Carmen G., Eduardo Zarzuela, Ruth Álvarez, et al.. (2021). KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform. Proceedings of the National Academy of Sciences. 118(30). 12 indexed citations
8.
Ortega-Molina, Ana, Cristina Lebrero‐Fernández, Nerea Deleyto-Seldas, et al.. (2021). Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Reports. 36(2). 109372–109372. 7 indexed citations
9.
Esteban-Burgos, Laura, Haiyun Wang, Jie Zheng, et al.. (2020). Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas. Proceedings of the National Academy of Sciences. 117(39). 24415–24426. 15 indexed citations
10.
Maestre, Lorena, Juan F. Garcı́a, Santiago Montes‐Moreno, et al.. (2020). High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations. PLoS ONE. 15(2). e0229743–e0229743. 11 indexed citations
11.
Roldán‐Romero, Juan María, María Santos, Javier Lanillos, et al.. (2020). Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. Modern Pathology. 33(12). 2580–2590. 34 indexed citations
12.
Quintela-Fandiño, Miguel, Serafín Morales, Luís Manso, et al.. (2019). Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer. Clinical Cancer Research. 26(1). 35–45. 32 indexed citations
13.
Hardisson, David, et al.. (2016). Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution.. PubMed. 57(2). 187–216. 6 indexed citations
14.
Caleiras, Eduardo, et al.. (2015). [Cadherins E and P expression in the molecular types of breast cancer].. PubMed. 56(2). 155–68. 1 indexed citations
15.
Herrera, Víctor Gallego, et al.. (2010). Adenocarcinoma de Pezón. A Propósito de un Caso. Redalyc (Universidad Autónoma del Estado de México). 22(1). 51–56. 1 indexed citations
16.
Caleiras, Eduardo, et al.. (2008). [HER2/neu expression in Venezuelan patients with locally advanced breast cancer].. PubMed. 49(1). 69–78. 4 indexed citations
17.
Caleiras, Eduardo, et al.. (2005). Adenocarcinoma Primario De Trompa Uterina.: A Propósito De Un Caso Y Revisión De La Literatura.. Redalyc (Universidad Autónoma del Estado de México). 17(2). 98–102. 1 indexed citations
18.
Caleiras, Eduardo, et al.. (2004). Extranodal Rosai–Dorfman disease. Clinical and pathological characteristics in a patient with a pseudotumor of bone. Pathology - Research and Practice. 200(5). 423–426. 6 indexed citations
19.
Caleiras, Eduardo, et al.. (1998). Tumor de Askin: estudio inmunohistoquímico y ultraestructural en dos casos. 36(2). 135–139. 1 indexed citations
20.
Caleiras, Eduardo, et al.. (1993). The Pulmonary Pathology in the Acquired Immunodeficiency Syndrome (Aids). 2(1). 99–108. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chan Zhu Breakdown of academic impact, for papers by David Crawford Breakdown of academic impact, for papers by Núria Coll-Bonfill Breakdown of academic impact, for papers by Dong Qian Breakdown of academic impact, for papers by Joanne Cox Breakdown of academic impact, for papers by Louise Munkhaus Petersen Breakdown of academic impact, for papers by Christine Birdwell Breakdown of academic impact, for papers by Doran Khamis Breakdown of academic impact, for papers by Yueh‐Te Lin Breakdown of academic impact, for papers by Ke Zheng
Rankless by CCL
2026